Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prediction of Preterm Labor in Asymptomatic High Risk Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03334877
Recruitment Status : Completed
First Posted : November 7, 2017
Last Update Posted : November 8, 2017
Sponsor:
Information provided by (Responsible Party):
Mohamed lotfy, Zagazig University

Brief Summary:

Two hundred and twenty women with singleton pregnancies and risk factors for spontaneous preterm birth were included in this study. Cervico vaginal fluid sampling was undertaken for qualitative assessment of β -human chorionic gonadotropin (β-hCG) and fetal fibronectin(fFN)at 24 weeks of gestation.

For qualitative assay of both b-hCG and fFN, first vaginal specimens were collected by the following method:

Specimen collection

A sterile Cusco speculum was introduced into the vagina; the anterior lip of the cervix was grasped with sponge forceps and a cotton-tipped swab was placed into the external part of the endocervical canal (not reaching the internal os) and then into the posterior fornix (each for at least 1 min) to obtain an adequate sample of cervico vaginal secretions. Sampling was performed before doing any cervical manipulation (digital or ultrasound examination) and before introducing any vaginal material (lubricants or medications). The Hologic Specimen Collection Kit is the only acceptable specimen collection system which can be used to collect specimens for this assay. The polyester tipped swab provided in the Specimen Collection Kit should be inserted into the vagina and lightly rotated across the posterior fornix for approximately 10 seconds to absorb the cervico vaginal secretions. Once the specimen is obtained, carefully remove the swab from the vagina and place it into the tube of buffer provided with the Specimen Collection Kit. Two Specimen Collection Device per patient were obtained; one for each assay. Label the Specimen Transport Tubes with the patient's name and any other identifying information required.

All women were then followed up till delivery. Women were categorized into two arms: women who delivered preterm (before 37 completed weeks of gestation) and women who delivered at term (after 37 completed weeks of gestation).


Condition or disease Intervention/treatment
Preterm Labor Diagnostic Test: β -human chorionic gonadotropin

  Show Detailed Description

Layout table for study information
Study Type : Observational
Actual Enrollment : 220 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: Cervicovaginal Fluid B-hCG Versus Fetal Fibronectin Assay in Prediction of Preterm Labor in Asymptomatic High Risk Women
Actual Study Start Date : May 15, 2015
Actual Primary Completion Date : May 10, 2017
Actual Study Completion Date : October 1, 2017

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
β -human chorionic gonadotropin
Cervico vaginal fluid sampling was undertaken for qualitative assessment of β -human chorionic gonadotropin (β-hCG) and fetal fibronectin(fFN) at 24 weeks of gestation to predict preterm labour in asymptomatic high risk patients
Diagnostic Test: β -human chorionic gonadotropin
Cervico vaginal fluid sampling was undertaken for qualitative assessment of β -human chorionic gonadotropin (β-hCG) and fetal fibronectin(fFN) at 24 weeks of gestation.




Primary Outcome Measures :
  1. The diagnostic accuracy of qualitative level of cervico vaginal β-hCG versus fetal fibronectin [ Time Frame: From 24 weeks gestation till delivery ]
    Prediction of preterm labor in asymptomatic high risk women during antenatal care.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 34 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Two hundred and twenty women with singleton pregnancies and risk factors for spontaneous preterm birth were included in this study at 24 weeks of gestation.
Criteria

Inclusion Criteria:

  • There were past history of one or more spontaneous preterm labor or preterm rupture of membranes at less than 37 weeks of gestation.
  • previous spontaneous second trimester miscarriage.
  • previous cervical surgery (large loop excision of the transformation zone, loop electrosurgical excision procedure, laser or cone excision).
  • accidental finding of a cervical length of 25 mm or less in the current pregnancy.

Exclusion Criteria:

  • Women who reported prior sexual intercourse (within 24 hours).
  • confirmed or suspected rupture of membranes.
  • vaginal bleeding visible on the swab.

Layout table for additonal information
Responsible Party: Mohamed lotfy, assistant Professor of Obstetrics and Gynecology, Zagazig University
ClinicalTrials.gov Identifier: NCT03334877     History of Changes
Other Study ID Numbers: ZUH 50
First Posted: November 7, 2017    Key Record Dates
Last Update Posted: November 8, 2017
Last Verified: November 2017

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Premature Birth
Obstetric Labor, Premature
Obstetric Labor Complications
Pregnancy Complications
Chorionic Gonadotropin
Reproductive Control Agents
Physiological Effects of Drugs